메뉴 건너뛰기




Volumn 43, Issue 1, 2011, Pages 60-64

Co-localization of mutant p53 and amyloid-like protein aggregates in breast tumors

Author keywords

Antibody A11; Breast cancer; Mutation; p53; Protein aggregate

Indexed keywords

A11 ANTIBODY; AMYLOID PROTEIN; ANTIBODY; PARAFFIN; PROTEIN P53; UNCLASSIFIED DRUG;

EID: 78650251684     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2010.10.017     Document Type: Article
Times cited : (116)

References (23)
  • 1
    • 77449150586 scopus 로고    scopus 로고
    • The p53 core domain is a molten globule at low pH: Functional implications of an intrinsically partially unfolded structure
    • A.P.D. Ano Bom, M.S. Freitas, F.S. Moreira, D. Foguel, A.P. Valente, and Y. Cordeiro The p53 core domain is a molten globule at low pH: functional implications of an intrinsically partially unfolded structure J Biol Chem 285 2009 2857 2866
    • (2009) J Biol Chem , vol.285 , pp. 2857-2866
    • Ano Bom, A.P.D.1    Freitas, M.S.2    Moreira, F.S.3    Foguel, D.4    Valente, A.P.5    Cordeiro, Y.6
  • 3
    • 1242318518 scopus 로고    scopus 로고
    • P53 protein variants: Structural and functional similarities with p63 and p73 isoforms
    • S. Courtois, C.C. de Fromentel, and P. Hainaut P53 protein variants: structural and functional similarities with p63 and p73 isoforms Oncogene 23 2004 631 638
    • (2004) Oncogene , vol.23 , pp. 631-638
    • Courtois, S.1    De Fromentel, C.C.2    Hainaut, P.3
  • 5
    • 0026072872 scopus 로고
    • Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
    • C.W. Elston, and I.O. Ellis Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up Histopathology 19 1991 403 410
    • (1991) Histopathology , vol.19 , pp. 403-410
    • Elston, C.W.1    Ellis, I.O.2
  • 6
    • 4644293577 scopus 로고    scopus 로고
    • Conformation-dependent antibodies target diseases of protein misfolding
    • C.G. Glabe Conformation-dependent antibodies target diseases of protein misfolding Trends Biochem Sci 29 2004 542 547
    • (2004) Trends Biochem Sci , vol.29 , pp. 542-547
    • Glabe, C.G.1
  • 7
    • 57649148788 scopus 로고    scopus 로고
    • Structural classification of toxic amyloid oligomers
    • C.G. Glabe Structural classification of toxic amyloid oligomers J Biol Chem 283 2008 29639 29643
    • (2008) J Biol Chem , vol.283 , pp. 29639-29643
    • Glabe, C.G.1
  • 8
    • 32344444621 scopus 로고    scopus 로고
    • Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer
    • Y. Higashimoto, Y. Asanomi, S. Takakusagi, M.S. Lewis, K. Uosaki, and S.R. Durell Unfolding, aggregation, and amyloid formation by the tetramerization domain from mutant p53 associated with lung cancer Biochemistry 45 2006 1608 1619
    • (2006) Biochemistry , vol.45 , pp. 1608-1619
    • Higashimoto, Y.1    Asanomi, Y.2    Takakusagi, S.3    Lewis, M.S.4    Uosaki, K.5    Durell, S.R.6
  • 10
    • 4544253735 scopus 로고    scopus 로고
    • Reversible aggregation plays a crucial role on the folding landscape of p53 core domain
    • D. Ishimaru, L.M. Lima, L.F. Maia, P.M. Lopez, A.P. Ano Bom, and A.P. Valente Reversible aggregation plays a crucial role on the folding landscape of p53 core domain Biophys J 87 2004 2691 2700
    • (2004) Biophys J , vol.87 , pp. 2691-2700
    • Ishimaru, D.1    Lima, L.M.2    Maia, L.F.3    Lopez, P.M.4    Ano Bom, A.P.5    Valente, A.P.6
  • 12
  • 13
    • 33646757232 scopus 로고    scopus 로고
    • The complexity of p53 stabilization and activation
    • M.F. Lavin, and N. Gueven The complexity of p53 stabilization and activation Cell Death Differ 13 2006 941 950
    • (2006) Cell Death Differ , vol.13 , pp. 941-950
    • Lavin, M.F.1    Gueven, N.2
  • 14
    • 0037470615 scopus 로고    scopus 로고
    • Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant
    • A.S. Lee, C. Galea, E.L. DiGiammarino, B. Jun, G. Murti, and R.C. Ribeiro Reversible amyloid formation by the p53 tetramerization domain and a cancer-associated mutant J Mol Biol 327 2003 699 709
    • (2003) J Mol Biol , vol.327 , pp. 699-709
    • Lee, A.S.1    Galea, C.2    Digiammarino, E.L.3    Jun, B.4    Murti, G.5    Ribeiro, R.C.6
  • 15
    • 77955363995 scopus 로고    scopus 로고
    • TP53 mutations in human cancers: Origins, consequences, and clinical use
    • M. Olivier, M. Hollstein, and P. Hainaut TP53 mutations in human cancers: origins, consequences, and clinical use Cold Spring Harb Perspect Biol 2 2010 a001008
    • (2010) Cold Spring Harb Perspect Biol , vol.2 , pp. 001008
    • Olivier, M.1    Hollstein, M.2    Hainaut, P.3
  • 17
    • 33644772215 scopus 로고    scopus 로고
    • The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer
    • M. Olivier, A. Langerød, P. Carrieri, J. Bergh, S. Klaar, and J. Eyfjord The clinical value of somatic TP53 gene mutations in 1,794 patients with breast cancer Clin Cancer Res 12 2006 1157 1167
    • (2006) Clin Cancer Res , vol.12 , pp. 1157-1167
    • Olivier, M.1    Langerød, A.2    Carrieri, P.3    Bergh, J.4    Klaar, S.5    Eyfjord, J.6
  • 18
    • 34047207337 scopus 로고    scopus 로고
    • TP53 mutations in human cancers: Functional selection and impact on cancer prognosis and outcomes
    • A. Petitjean, M.I. Achatz, A.L. Borresen-Dale, P. Hainaut, and M. Olivier TP53 mutations in human cancers: functional selection and impact on cancer prognosis and outcomes Oncogene 26 2007 2157 2165
    • (2007) Oncogene , vol.26 , pp. 2157-2165
    • Petitjean, A.1    Achatz, M.I.2    Borresen-Dale, A.L.3    Hainaut, P.4    Olivier, M.5
  • 19
    • 43649108895 scopus 로고    scopus 로고
    • The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies
    • S. Rigacci, M. Bucciantini, A. Relini, A. Pesce, A. Gliozzi, and A. Berti The (1-63) region of the p53 transactivation domain aggregates in vitro into cytotoxic amyloid assemblies Biophys J 94 2008 3635 3646
    • (2008) Biophys J , vol.94 , pp. 3635-3646
    • Rigacci, S.1    Bucciantini, M.2    Relini, A.3    Pesce, A.4    Gliozzi, A.5    Berti, A.6
  • 20
    • 77951977004 scopus 로고    scopus 로고
    • Protein kinetic stability
    • J.M. Sanchez-Ruiz Protein kinetic stability Biophys Chem 148 2010 1 15
    • (2010) Biophys Chem , vol.148 , pp. 1-15
    • Sanchez-Ruiz, J.M.1
  • 21
    • 77249149930 scopus 로고    scopus 로고
    • Ligand binding and hydration in protein misfolding: Insights from studies of prion and p53 tumor suppressor protein
    • J.L. Silva, T.C. Vieira, M.P. Gomes, A.P. Bom, L.M. Lima, and M.S. Freitas Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor protein Acc Chem Res 43 2010 271 279
    • (2010) Acc Chem Res , vol.43 , pp. 271-279
    • Silva, J.L.1    Vieira, T.C.2    Gomes, M.P.3    Bom, A.P.4    Lima, L.M.5    Freitas, M.S.6
  • 22
    • 0036722817 scopus 로고    scopus 로고
    • TP53 mutations in breast cancer tumors of patients from Rio de Janeiro Brazil: Association with risk factors and tumor characteristics
    • T.A. Simao, F.S. Ribeiro, L.M. Amorim, R.M. Albano, M.J. Andrada-Serpa, and L.E. Cardoso TP53 mutations in breast cancer tumors of patients from Rio de Janeiro Brazil: association with risk factors and tumor characteristics Int J Cancer 101 2002 69 73
    • (2002) Int J Cancer , vol.101 , pp. 69-73
    • Simao, T.A.1    Ribeiro, F.S.2    Amorim, L.M.3    Albano, R.M.4    Andrada-Serpa, M.J.5    Cardoso, L.E.6
  • 23
    • 77954358960 scopus 로고    scopus 로고
    • Mysterious oligomerization of the amyloidogenic proteins
    • V.N. Uversky Mysterious oligomerization of the amyloidogenic proteins FEBS J 2010 2940 2953
    • (2010) FEBS J , pp. 2940-2953
    • Uversky, V.N.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.